Hodgkin Disease

Hodgkin disease is a cancer of the lymphatic system that results from abnormal growth of cells in the lymphatic system. These cells can spread to other parts of the body. It can affect people of any age, but it is most common in people between the ages of 20 and 40 and over the age of 55.

Showing 1–12 of 19 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Brentuximab vedotin	CD30	Antibody-drug conjugate (ADC)	Adcetris®	5 mg/mL	–	2 mg	-80°C	tba	785,00 €	view product Max: 10 Min: 6 Step: 1
Nivolumab 8006657	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2024	307,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab 8038581	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2025	307,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab 8039750	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	03/2025	307,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAN6970	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2018	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAP6351	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	10/2018	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAQ3795	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	02/2018	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAU3964	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	05/2019	276,30 €	view product Max: 7 Min: 1 Step: 1
Nivolumab AAW0883	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	01/2019	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAW6409	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	09/2020	276,30 €	view product Max: 7 Min: 1 Step: 1
Nivolumab AAX0742	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	11/2020	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAY2764	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	02/2021	276,30 €	view product Max: 6 Min: 1 Step: 1
Pembrolizumab 6302603D04	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	07/2018	451,80 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302601E01	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	12/2018	451,80 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302607002	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	03/2019	451,80 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302613A05	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	07/2019	451,80 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab U001450	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	yes	2 mg	-80°C	04/2022	564,30 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab U029851	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	11/2022	451,80 €	view product Max: 2 Min: 1 Step: 1
Pembrolizumab W038747	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	04/2024	502,00 €	view product Max: 10 Min: 1 Step: 1

Not looking for Hodgkin Disease?

Search our therapeutic molecules product database